Cargando…
Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy
Although nano-immunotherapy has advanced dramatically in recent times, there remain two significant hurdles related to immune systems in cancer treatment, such as (namely) inevitable immune elimination of nanoplatforms and severely immunosuppressive microenvironment with low immunogenicity, hamperin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382433/ https://www.ncbi.nlm.nih.gov/pubmed/36017071 http://dx.doi.org/10.1016/j.bioactmat.2022.07.023 |
_version_ | 1784769280032636928 |
---|---|
author | Chen, Biao-Qi Zhao, Yi Zhang, Yang Pan, Yu-Jing Xia, Hong-Ying Kankala, Ranjith Kumar Wang, Shi-Bin Liu, Gang Chen, Ai-Zheng |
author_facet | Chen, Biao-Qi Zhao, Yi Zhang, Yang Pan, Yu-Jing Xia, Hong-Ying Kankala, Ranjith Kumar Wang, Shi-Bin Liu, Gang Chen, Ai-Zheng |
author_sort | Chen, Biao-Qi |
collection | PubMed |
description | Although nano-immunotherapy has advanced dramatically in recent times, there remain two significant hurdles related to immune systems in cancer treatment, such as (namely) inevitable immune elimination of nanoplatforms and severely immunosuppressive microenvironment with low immunogenicity, hampering the performance of nanomedicines. To address these issues, several immune-regulating camouflaged nanocomposites have emerged as prevailing strategies due to their unique characteristics and specific functionalities. In this review, we emphasize the composition, performances, and mechanisms of various immune-regulating camouflaged nanoplatforms, including polymer-coated, cell membrane-camouflaged, and exosome-based nanoplatforms to evade the immune clearance of nanoplatforms or upregulate the immune function against the tumor. Further, we discuss the applications of these immune-regulating camouflaged nanoplatforms in directly boosting cancer immunotherapy and some immunogenic cell death-inducing immunotherapeutic modalities, such as chemotherapy, photothermal therapy, and reactive oxygen species-mediated immunotherapies, highlighting the current progress and recent advancements. Finally, we conclude the article with interesting perspectives, suggesting future tendencies of these innovative camouflaged constructs towards their translation pipeline. |
format | Online Article Text |
id | pubmed-9382433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-93824332022-08-24 Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy Chen, Biao-Qi Zhao, Yi Zhang, Yang Pan, Yu-Jing Xia, Hong-Ying Kankala, Ranjith Kumar Wang, Shi-Bin Liu, Gang Chen, Ai-Zheng Bioact Mater Review Article Although nano-immunotherapy has advanced dramatically in recent times, there remain two significant hurdles related to immune systems in cancer treatment, such as (namely) inevitable immune elimination of nanoplatforms and severely immunosuppressive microenvironment with low immunogenicity, hampering the performance of nanomedicines. To address these issues, several immune-regulating camouflaged nanocomposites have emerged as prevailing strategies due to their unique characteristics and specific functionalities. In this review, we emphasize the composition, performances, and mechanisms of various immune-regulating camouflaged nanoplatforms, including polymer-coated, cell membrane-camouflaged, and exosome-based nanoplatforms to evade the immune clearance of nanoplatforms or upregulate the immune function against the tumor. Further, we discuss the applications of these immune-regulating camouflaged nanoplatforms in directly boosting cancer immunotherapy and some immunogenic cell death-inducing immunotherapeutic modalities, such as chemotherapy, photothermal therapy, and reactive oxygen species-mediated immunotherapies, highlighting the current progress and recent advancements. Finally, we conclude the article with interesting perspectives, suggesting future tendencies of these innovative camouflaged constructs towards their translation pipeline. KeAi Publishing 2022-08-10 /pmc/articles/PMC9382433/ /pubmed/36017071 http://dx.doi.org/10.1016/j.bioactmat.2022.07.023 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Chen, Biao-Qi Zhao, Yi Zhang, Yang Pan, Yu-Jing Xia, Hong-Ying Kankala, Ranjith Kumar Wang, Shi-Bin Liu, Gang Chen, Ai-Zheng Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy |
title | Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy |
title_full | Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy |
title_fullStr | Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy |
title_full_unstemmed | Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy |
title_short | Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy |
title_sort | immune-regulating camouflaged nanoplatforms: a promising strategy to improve cancer nano-immunotherapy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382433/ https://www.ncbi.nlm.nih.gov/pubmed/36017071 http://dx.doi.org/10.1016/j.bioactmat.2022.07.023 |
work_keys_str_mv | AT chenbiaoqi immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy AT zhaoyi immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy AT zhangyang immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy AT panyujing immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy AT xiahongying immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy AT kankalaranjithkumar immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy AT wangshibin immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy AT liugang immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy AT chenaizheng immuneregulatingcamouflagednanoplatformsapromisingstrategytoimprovecancernanoimmunotherapy |